Amgen Inc. Earnings

Amgen Inc.’s revenue jumped 12.4% since last year same period to $9557Mn in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 4.25% jump in its revenue since last 3-months.

Amgen Inc.’s net profit jumped 13.64% since last year same period to $3216Mn in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 124.58% jump in its net profits since last 3-months.

Amgen Inc.’s net profit margin jumped 1.11% since last year same period to 33.65% in the Q3 2025. On a quarterly growth basis, Amgen Inc. has generated 115.42% jump in its net profit margins since last 3-months.

Amgen Inc.’s earning per share (EPS) estimates for the current quarter stand at 5.02 - a -4.92% fall from last quarter’s estimates.

Amgen Inc.’s earning per share (EPS) estimates for the current year stand at 5.02.

Amgen Inc.’s earning per share (EPS) jumped 21.13% since last year same period to 6.02 in the Q2 2025. This indicates that the Amgen Inc. has generated 21.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Amgen Inc. declared 2.38 dividend per share during the earnings announcement for Q2 2025.